BUY Kaynes Technology India Ltd. — Rajesh Palviya, Axis Securities
byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))25 Aug 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Kaynes Tech, Dixon Tech, Syrma shares rise up to 2% after govt notifies Rs 62,500 cr mobile manufacturing scheme
NewsEt-Markets·24 Aug · yesterday
1 advisor has an active short-term BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·24 Aug · yesterday
Kaynes Technology India Ltd has signed a strategic MoU with BOSGAME to establish a strong computing presence in India.
BSE · Company Update·22 Aug · 2d ago
1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·19 Aug · 5d ago
Kaynes, Micromax Arm, Wipro Plants To Go Live Soon As Govt Clears Rs 7,877 Cr ECMS Tranche
NewsNdtv-Profit·17 Aug · 1w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Kaynes Technology India
- SELL — Kunal Bothra21 Oct 2026 · Same day · target ₹3,080 · Expired
- SELL — Rakesh Bansal9 Oct 2026 · ~2 weeks · target ₹3,110 · SL hit
- SELL — Rakesh Bansal8 Oct 2026 · Same day · target ₹3,220 · Expired
- SELL — Somil Mehta, Sharekhan6 Oct 2026 · ~2 weeks · target ₹3,000 · Expired
- SELL — Prakash Gaba29 Sept 2026 · Next day · target ₹3,450 · SL hit
More from Rajesh Palviya, Axis Securities
- BUY Sansera Engineering8 Oct 2026 · ~2 weeks · target ₹4,350 · SL hit
- BUY Trent8 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- SELL Sun Pharmaceutical Industries5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY Cipla29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY Zydus Lifesciences29 Sept 2026 · ~2 weeks · target ₹1,280 · SL hit

